Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).

Bhuriya, Rohit; Li, Suying; Chen, Shu-Cheng; McCullough, Peter A; Bakris, George L

Bhuriya, Rohit; Li, Suying; Chen, Shu-Cheng; McCullough, Peter A; Bakris, George L.

Affiliation

Bhuriya R; Department of Medicine, Chicago Medical School, North Chicago, IL, USA.

Am J Kidney Dis ; 53(4 Suppl 4): S3-10, 2009 Apr.

Article in En | MEDLINE | ID: mdl-19285609

Subject(s)

Cardiovascular Diseases/epidemiology; Kidney Failure, Chronic/epidemiology; Mass Screening/statistics & numerical data; Parathyroid Hormone/blood; Age Factors; Aged; Blood Pressure/physiology; Calcium/blood; Cardiovascular Diseases/blood; Comorbidity; Cross-Sectional Studies; Female; Glomerular Filtration Rate/physiology; Health Surveys; Hemoglobinometry; Humans; Hyperparathyroidism, Secondary/blood; Hyperparathyroidism, Secondary/epidemiology; Kidney Failure, Chronic/blood; Male; Middle Aged; Phosphorus/blood; Risk Factors; United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Parathyroid Hormone / Cardiovascular Diseases / Mass Screening / Kidney Failure, Chronic Type of study: Etiology_studies / Evaluation_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Country/Region as subject: America do norte Language: En Journal: Am J Kidney Dis Year: 2009 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google